Mr. Kam added, "Our cord blood bank business has stepped up the pace of its expansion plan outside China. We, through a strategic ownership of Cordlife Ltd., the largest cord blood bank operator in Southeast Asia, have become one of the world's largest cord blood bank operators in terms of population coverage. The listing in the U.S. will help the division speed up the pace of geographical expansion in China and overseas. Up to the date, it is the first Chinese healthcare enterprise listed in the U.S. this year."
He concluded, "To capture the unique opportunities brought by new medical reforms in China, the Group strategically extended its footholds in the hospital management and services industry. Synergistic effects with the existing businesses resulted and the move helped us to provide all round healthcare products and services to the Chinese public through our integrated operations. This also enhanced the Group's competitiveness in China."
Among the Group's strategic investments, Pypo Digital Company Limited, a fast-moving consumer electronics distributor and retailer, will be listed in the U.S. soon.
Golden Meditech Company Limited (the "Company" or "Golden Meditech"; stock
code: 801), together with its subsidiaries (collectively referred to as the
"Group"), is a leading healthcare corporation in China. Golden Meditech
operates an integrated portfolio of healthcare businesses including the
manufacturing of medical devices, the provision of healthcare services and the
production of natural herbal medicines. It has gained dominant market
'/>"/>
| SOURCE Golden Meditech Company Limited Copyright©2009 PR Newswire. All rights reserved |